Arizona Tribune - Boulevard

NYSE - LSE

CMSC	0.19%	21.03	$
RBGPF	-0.99%	70	$
RELX	-1.56%	35.15	$
BCC	0.62%	76.31	$
RYCEF	-0.25%	19.75	$
VOD	0.12%	16.07	$
RIO	0.87%	102.75	$
CMSD	0.05%	20.79	$
BCE	-0.04%	23.4	$
NGG	-1.41%	78.05	$
JRI	-0.75%	12.08	$
AZN	-0.52%	161.63	$
BP	-1.23%	43.93	$
GSK	-0.44%	50.44	$
BTI	-0.43%	55.68	$

Featured

US jury deadlocks again in Lindsay Clancy's child murder trial

A US judge on Wednesday sent jurors back for a final push toward a verdict in Lindsay Clancy's triple murder trial after they deadlocked for a second time, raising the prospect of a mistrial.

Maltese tycoon acquitted of masterminding reporter's murder

A Maltese court on Wednesday acquitted tycoon Yorgen Fenech of orchestrating the murder in 2017 of investigative reporter Daphne Caruana Galizia, which brought down a government and drew global condemnation.

Last news

South Korea court upholds President Yoon's impeachment, strips him of office

South Korea's Constitutional Court on Friday upheld President Yoon Suk Yeol's impeachment over his disastrous martial law declaration, voting unanimously to strip him of office for violating the constitution.

Irish school trains thatchers to save iconic roofs

A new school in Ireland is training up a fresh generation of thatchers in a bid to save the country's disappearing thatched roofs, an iconic feature of the Irish landscape.

New to The Street to Broadcast Tonight at 9:30 PM PST on Bloomberg Television as Sponsored Programming Kevin Harrington, the Original Shark, Meets with The Sustainable Green Team to Discuss the Revolutionary Waterless Garden

NEW YORK CITY, NEW YORK / ACCESS Newswire / April 4, 2025 / New to The Street, the premier business television series highlighting innovative companies and market disruptors, will air tonight at 9:30 PM PST on Bloomberg Television as sponsored programming.

Aptevo Therapeutics Announces the Closing of $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

SEATTLE, WASHINGTON / ACCESS Newswire / April 4, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, announced the closing of its previously announced offering of 1,764,710 shares of the Company's common stock in a registered direct offering and warrants to purchase up to 3,529,420 shares of common stock in a concurrent private placement (together with the registered direct offering, the "offering") at a combined purchase price of $1.19 per share and accompanying warrant. The warrants issued pursuant to the concurrent private placement have an exercise price of $1.19 per share, will be exercisable upon the receipt of stockholder approval and will expire 5 years from the date of stockholder approval.

LAMY Forms Strategic Partnership with a Renowned Family, Pioneering New Integration of NFTs and Education

NEW YORK CITY, NEW YORK / ACCESS Newswire / April 4, 2025 / LAMY Inc. (NASDAQ:LMMY), an innovative technology company dedicated to transforming children's financial literacy education through gamified and immersive e-learning experiences, today announced a strategic partnership with a renowned family. This collaboration marks a significant milestone in LAMY's global expansion, integrating art, cultural heritage, and digital innovation into its flagship product, TwoPlus1®.

Polaris Renewable Energy Announces Q1 2025 Investor Call Details

TORONTO, ON / ACCESS Newswire / April 4, 2025 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") is pleased to announce it will be holding its Earnings Conference Call and Webcast to report its Q1 2025 Earnings Results on Thursday, May 1st, 2025, at 10:00 am EST.

South Korea court to decide impeached president's fate

The fate of South Korea's presidency hangs on the Constitutional Court Friday as it decides whether to uphold Yoon Suk Yeol's impeachment over a disastrous martial law declaration or to return him to power.

Zuckerberg repeats Trump visits in bid to settle antitrust case

Meta boss Mark Zuckerberg has made repeated visits to the White House as he tries to persuade US President Donald Trump to settle a major antitrust case before it goes to trial on April 14, US media reported.

French creche worker gets 25 years for killing baby with drain cleaner

A French ex-daycare worker on Thursday was sentenced to 25 years in prison over a baby's death in her care, after she gave the infant drain cleaner to silence her crying.

Ancelotti’s tax trial wraps up in Spain with prosecutors seeking jail

Real Madrid coach Carlo Ancelotti's tax fraud trial wrapped up Thursday in Spain, with public prosecutors seeking he be jailed for four years and nine months for allegedly hiding income from the tax office.

Prosecutors demand jail term for Ancelotti for tax fraud

Real Madrid coach Carlo Ancelotti's tax fraud trial wrapped up Thursday in Spain, with public prosecutors seeking demanding he be jailed for four years and nine months for allegedly hiding income from the tax office.

Iconic Paris hotel Lutetia taken over by Mandarin Oriental

The historic Lutetia hotel in Paris, occupied by the Nazis during World War II and after liberation serving as a welcome centre for concentration camp survivors, was on Thursday taken over by luxury hotel group Mandarin Oriental.

UK show reveals tawdry tale of Shakespeare folio theft

The gripping tale of how a 400-year-old edition of the first collection of William Shakespeare plays was stolen, recovered and restored is to be explored in a new UK exhibition, it was announced Thursday.

Search for Malaysia's long missing MH370 suspended

The latest search for Malaysia Airlines flight MH370 has been suspended by maritime exploration firm Ocean Infinity as it is "not the season", Kuala Lumpur's transport minister said, more than a decade after the plane went missing.

Malaysia suspends search for long-missing flight MH370

The latest search for Malaysia Airlines flight MH370 has been suspended as it is "not the season", Kuala Lumpur's transport minister said, more than a decade after the plane went missing.

Search for long-missing flight MH370 suspended: Malaysia minister

The latest search for Malaysia Airlines flight MH370 has been suspended, Kuala Lumpur's transport minister said, more than a decade after the plane went missing.

Israel's Netanyahu arrives in Hungary, defying ICC warrant

Israeli Prime Minister Benjamin Netanyahu arrived in Budapest early Thursday on his first trip to Europe since 2023 and in defiance of the International Criminal Court (ICC)'s arrest warrant against him.

Starbucks faces new hot spill lawsuits weeks after $50mn ruling

Starbucks was facing two new lawsuits over spilled hot drinks Wednesday, just weeks after a court ordered the coffee giant to pay $50 million to a man who was injured by a cup of tea.

Arthritis Foundation and American College of Rheumatology Denounce the Dismantling of Programs Critical to Arthritis Research and Chronic Disease Prevention

ATLANTA, GA / ACCESS Newswire / April 3, 2025 / As organizations representing nearly 60 million adults and children living with arthritis in the United States and the rheumatologists and health care professionals who treat them, we are deeply alarmed by this week's dismantling of multiple branches of the Centers for Disease Control and Prevention (CDC) that manage essential research and public health programs critical to the well-being of millions of people living with chronic conditions.

Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025

VANCOUVER, BC / ACCESS Newswire / April 3, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly owned subsidiary, Inka Health Corp. ("Inka Health"), which the Company acquired on or about February 3, 2025 (please see news release dated February 3, 2025), has now successfully completed analytical work under contract ("AZ Services Agreement") for AstraZeneca Canada ("AstraZeneca"), contributing to ongoing advancements in pharmaceutical evidence generation.

Exploring AI in Healthcare Facilities: David Trask, National Director at ARC Facilities, to Present Educational Session at TAHFM Conference

Session to explore compliance, efficiency, and team collaboration in healthcare environments

Pebble Beach Resorts and the USGA Launch Championship Logo to Kick Off 2027 U.S. Open

The U.S. Open returns to Pebble Beach Golf Links for the seventh time

Watzke elected as UEFA Vice-President

DORTMUND, DE / ACCESS Newswire / April 3, 2025 / The Chairman of the Management Board of Borussia Dortmund GmbH & Co. KGaA, Hans-Joachim Watzke, was re-elected to the Executive Committee of European soccer's governing body at today's UEFA Congress in Belgrade.The 65-year-old received 48 votes in the first round of voting by the 55 UEFA associations and was consequently confirmed as Executive Committee member for a further four years.During the subsequent meeting of the Executive Committee, Watzke was also unanimously elected as one of the UEFA vice-presidents.Dortmund, 03. April 2025Borussia Dortmund GmbH & Co. KGaABorussia Dortmund Geschäftsführungs-GmbH

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, today announced the closing of the previously announced registered direct offering with institutional investors of approximately $2.46 million of shares of Common Stock and pre-funded warrants at a price of $2.07 per share of Common Stock. The entire transaction was priced at the market under Nasdaq rules.

Exousia Pro Issues Update on Name Change

ORLANDO, FLORIDA / ACCESS Newswire / April 3, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is pleased to announce that the Company has received comments from FINRA regarding the name change.

UniDoc Announces Debt Settlement and Renews Marketing Engagement

VANCOUVER, BC / ACCESS Newswire / April 3, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company") announces that it intends to settle $93,240 (equivalent to approximately €60,000) in debt owed to a certain creditor of the Company by issuing approximately 266,400 common shares of the Company at a deemed price of $0.35 per share (the "Debt Settlement"). The creditor is a company controlled by a director of the Company.

NextTrip Holdings and Intimate Hotels of Barbados Forge Strategic Partnership to Enhance Caribbean Travel Experience

NextTrip's Technology Platform will be Integrated to Provide Guests with a Streamlined and Intuitive Booking Experience

Dolphin CEO Bill O'Dowd Starts $250,000 10b5-1 Stock Purchase Plan This Week, Building on $100,000 Purchase in 2H 2024; Bullish on Dolphin’s Undervalued Shares and Future Growth

MIAMI, FL / ACCESS Newswire / April 3, 2025 / Dolphin (NASDAQ:DLPN), a leading entertainment marketing and content production company, today announced that CEO Bill O'Dowd has initiated a 10b5-1 trading plan to purchase an initial $250,000 of the Company's common stock, building upon his $100,000 investment in Dolphin in the second half of 2024.

Xebra Brands’ Largest Shareholder Increases Stake as Company Explores Landmark Agricultural Agreement in Mexico

VANCOUVER, BC / ACCESS Newswire / April 3, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a trailblazer in the Mexican cannabis sector and the sole company legally permitted to import seeds, cultivate, manufacture, operate, and sell cannabis (-1% THC) in Mexico, is excited to announce, that its largest shareholder, David Ross Macias Diaz (Mr. Diaz), has increased his position in the Company with the recent open market acquisition of 1,000,000 common shares.

Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

SEATTLE, WA / ACCESS Newswire / April 3, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, announced today that it has entered into definitive securities purchase agreements for the purchase and sale of 1,764,710 shares of the Company's common stock in a registered direct offering and warrants to purchase up to 3,529,420 shares of common stock in a concurrent private placement (together with the registered direct offering, the "offering") at a combined purchase price of $1.19 per share and accompanying warrant. The warrants issued pursuant to the concurrent private placement will have an exercise price of $1.19 per share, will be exercisable upon the receipt of shareholder approval following the date of issuance and will expire 5 years from the initial exercise date. The offering is expected to close on or about April 4, 2025 subject to the satisfaction of customary closing conditions.

LQR House Signs Exclusive Distribution Agreement with Of The Earth Distribution to Launch SWOL Tequila in Greece and Thailand

MIAMI BEACH, FLORIDA / ACCESS Newswire / April 3, 2025 / LQR House Inc. (the "Company" or "LQR House") (NASDAQ:YHC), a niche ecommerce platform specializing in the spirits and beverage industry, today announced that on April 1, 2025, it has entered into an exclusive agreement with Of The Earth Distribution ("OTE") to introduce its flagship brand, SWOL Tequila, to the markets of Greece and Thailand. The Company believes that this strategic partnership will leverage OTE's established sales and distribution networks to create demand and accelerate growth in these promising new regions.

CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company

BEIJING, CN / ACCESS Newswire / April 3, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI, "CASI"), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced that its special committee of the board of directors (the "Special Committee") has received an updated preliminary non-binding proposal letter (the "Proposal Letter"), dated April 2, 2025, from Dr. Wei-Wu He, Chairman of the board of directors and CEO of the Company, to acquire the entire business operations of the Company in China and all license-in, distribution and related rights in Asia (excluding Japan) related to certain pipeline products of the Company, including BI-1206, CID-103 and Thiotepa, for an aggregate purchase price of $20.0 million, which shall include assumption of approximately $20.0 million of indebtedness of the Company (the "Proposed Transaction").

Arizona Tribune - Boulevard (English)